Search results for “CD226” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 85 patents, we discovered top 26 key players by total patent application. Shanghai Longyao Biotech Co., Ltd., Eli Lilly & Co., Tessa Therapeutics Ltd are dominant in this area. They take 43.53% of the total patent filing.
Shanghai Longyao Biotech Co., Ltd.
Shanghai Shi, China
Patent: 15
Eli Lilly & Co.
Indiana, United States
Patent: 13
Tessa Therapeutics Ltd
Central Region, Singapore
Patent: 9
OncoMed Pharmaceuticals, Inc.
California, United States
Patent: 8
Epiontis GmbH
Berlin, Germany
Patent: 6
23andMe, Inc.
California, United States
Patent: 5
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 4
STARTUP
Systimmune, Inc.
Washington, United States
Patent: 3
Shandong Xingrui Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 3
Genentech, Inc.
California, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 4 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Systimmune, Inc.
Washington, United States
Patent: 3
STARTUP
Compass Therapeutics LLC
Massachusetts, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 64 patents applied in the last 5 years. We discover 24 most active companies in this area. The fast-growing Shanghai Longyao Biotech Co., Ltd., Eli Lilly & Co., 23andMe, Inc. take 51.56% of patent filing during this period.
Shanghai Longyao Biotech Co., Ltd.
Shanghai Shi, China
Patent: 15
Eli Lilly & Co.
Indiana, United States
Patent: 13
23andMe, Inc.
California, United States
Patent: 5
Kyoto University
Kyoto-fu, Japan
Patent: 4
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 4
Shandong Xingrui Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 3
STARTUP
Systimmune, Inc.
Washington, United States
Patent: 3
Fred Hutchinson Cancer Research Center
Washington, United States
Patent: 3
Nanjing Weiyade Biopharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Chengdu Bailidote Biological Pharmaceutical Co., Ltd.
China
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 64 patents in last 5 years, we discover 22 new entrants. Shanghai Longyao Biotech Co., Ltd., Eli Lilly & Co., 23andMe, Inc. are the most active new entrants in this area.
Shanghai Longyao Biotech Co., Ltd.
Shanghai Shi, China
Patent: 15
Eli Lilly & Co.
Indiana, United States
Patent: 13
23andMe, Inc.
California, United States
Patent: 5
Kyoto University
Kyoto-fu, Japan
Patent: 4
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 4
Shandong Xingrui Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 3
STARTUP
Systimmune, Inc.
Washington, United States
Patent: 3
Fred Hutchinson Cancer Research Center
Washington, United States
Patent: 3
Nanjing Weiyade Biopharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Chengdu Bailidote Biological Pharmaceutical Co., Ltd.
China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 18 patents, we discovered top 6 universities and scientific research institutions by total patent application. Kyoto University, Fourth Military Medical University, University of Bonn are dominant in this area. They take 61.11% of the total patent filing.
Kyoto University
Kyoto-fu, Japan
Patent: 4
Fourth Military Medical University
Hunan Sheng, China
Patent: 3
University of Bonn
Nordrhein-Westfalen, Germany
Patent: 1
University of Ulster
COLERAINE, United Kingdom
Patent: 1
Korea Institute of Science & Technology
South Korea
Patent: 1
Academy of Military Medical Sciences
China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: